Compare Airbnb, Inc. (ABNB) vs BioNTech SE - ADR (BNTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Airbnb, Inc. vs BioNTech SE - ADR — how do they compare? Airbnb, Inc. trades at $179.92 (market cap $110.76B), while BioNTech SE - ADR trades at $92.94 (market cap $23.31B). The key difference: Airbnb, Inc. is far larger — about 4.8× BioNTech SE - ADR's market cap, and Airbnb, Inc. is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| ABNB | BNTX | |
|---|---|---|
Market Cap | $110.76B | $23.31B |
Sector | Consumer Cyclical | Health |
52-Week High | $184.98 | $119.34 |
52-Week Low | $111.54 | $83.89 |
Enterprise Value | $101.19B | $6.60B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABNB trades at $179.40, down 2.87% over 24 hours, with a bullish technical outlook from moving averages but overbought RSI signals. The company reported Q2 2026 EPS of $1.37, beating expectations, and revenue growth continues with a 20.45% net income margin. Recent news highlights AI-driven growth and expansion into hotels and travel services.
Outlook is positive with strong analyst support and AI integration boosting efficiency, but high valuation ratios and competitive pressures pose risks. The consensus price target is $173.26, slightly below current price, indicating cautious optimism amid growth momentum.
BioNTech (BNTX) trades at $92.72, down 0.09% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 revenue of €106 million, missing expectations due to weak COVID-19 vaccine demand, and lowered its 2026 sales outlook. Despite negative profitability metrics (net income margin -63.64%, ROE -9.3%), the balance sheet remains strong with $16.78 billion in cash. Analyst consensus is strongly bullish with 87.5% buy ratings and a $121 price target.
The outlook for BNTX hinges on its oncology pipeline development amid declining COVID revenue. Investment opportunity exists in the discounted valuation relative to cash reserves and potential pipeline catalysts. Key risks include execution on pipeline transitions, competitive pressure, and ongoing vaccine demand volatility. The stock trades near cash value, implying the market assigns minimal value to its advanced clinical programs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Airbnb, Inc.
Airbnb, Inc. operates an online marketplace for travel information and booking services. The Company offers lodging, home stay, and tourism services via websites and mobile applications. Airbnb serves clients worldwide.
Read more on ABNB →About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →
